By Nick Paul Taylor
Full data from late-phase trials of AstraZeneca’s COVID-19 vaccine have pointed to the potential for AZD1222 to work after a single dose and prevent asymptomatic cases but left key questions about the efficacy of the candidate unanswered.
read more
By Heather Landi
Google is upping its focus on health research with a new mobile app that lets smartphone users participate in virtual health studies. The tech giant is going up against competitor Apple, which has made strides in remote research efforts since rolling out its first virtual health study in 2017. Here's what Google Health is focusing on with its remote health studies.
read more
By Eric Sagonowsky,Angus Liu,Kyle Blankenship,Conor Hale,Fraiser Kansteiner
Canada became the third country to authorize Pfizer's vaccine. Europe's drug regulator was the victim of a cyberattack. President-elect Biden plans to vaccinate 100 million Americans during his early days in office. In the push to allocate vaccines, states disagree on who's essential. Plus, Indonesia received its first shipment of Sinovac shots.
read more
By Conor Hale
The partnership aims to draw the line where antibody protection begins, and provide answers on whether booster shots will be needed to maintain immunity.
read more
By Tina Reed
Top execs from national retail pharmacy chains CVS and Walgreens say their infrastructure is ready and well-tested for the challenges ahead in distributing the COVID-19 vaccines once they become available.
read more
By Robert King
Care New England Heath System appeared to decline a purchase offer from StoneBridge Healthcare as it continues merger talks with Lifespan.
read more
